Back to search
FDAFDA · Food and drugs·Recall number D-0561-2024

Amoxicillin and Clavulanate Potassium Tablets USP, Chewable 400mg/57mg, 20-count bottles, Rx only, Manufactured in Canada By: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0093-2272-34

Published June 26, 2024 · Recall initiated: June 4, 2024

Summary

FDA records drug Class II recall D-0561-2024, published June 26, 2024 and initiated June 4, 2024. Recalling firm: Teva Pharmaceuticals USA, Inc; Status: Ongoing; Reported quantity: 34,448 bottles; Lot: Lot #: 100047634 Exp. Date 4/2025; 35449379A, Exp. Date 7/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teva Pharmaceuticals USA, Inc
Distributor
Nationwide within the United States
Lot
Lot #: 100047634 Exp. Date 4/2025; 35449379A, Exp. Date 7/2024
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Amoxicillin and Clavulanate Potassium Tablets USP, Chewable 400mg/57mg, 20-count bottles, Rx only, Manufactured in Canada By: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0093-2272-34 recalled?

Yes. FDA published recall D-0561-2024 on June 26, 2024. Reported hazard: Subpotent Drug

What should I do if I have this product?

Voluntary: Firm initiated